The New York Times
Moderna on Tuesday became the latest pharmaceutical company to apply to the FDA for full approval for its Covid-19 vaccine for use in people 18 and older. F.D.A. approval would allow the company to market the shot directly to consumers, and could also help raise public confidence in the vaccine. … Last month Pfizer and BioNTech applied to the agency for full approval of their vaccine for use in people 16 and older.